118 Zilberman MV, Witt SA, Kimball TR Is there a role for intravenous transpulmonary contrast imaging in pediatric stress echocardiography? J Am Soc Echocardiogr 2003;16:9–14 119 Ishii M, Himeno W, Sawa M, et al Assessment of the ability of myocardial contrast echocardiography with harmonic power doppler imaging to identify perfusion abnormalities in patients with kawasaki disease at rest and during dipyridamole stress Pediatr Cardiol 2002;23:192–199 120 Gibbons RJ, Balady GJ, Bricker JT, et al ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American college of Cardiology/American heart association task force on practice guidelines (committee to update the 1997 exercise testing guidelines) Circulation 2002;106:1883–1892 121 Greil GF, Stuber M, Botnar RM, et al Coronary magnetic resonance angiography in adolescents and young adults with kawasaki disease Circulation 2002;105:908–911 122 Danias PG, Stuber M, Botnar RM, et al Coronary MR angiography clinical applications and potential for imaging coronary artery disease Magn Reson Imaging Clin N Am 2003;11:81–99 123 Mavrogeni S, Papadopoulos G, Douskou M, et al Magnetic resonance angiography is equivalent to x-ray coronary angiography for the evaluation of coronary arteries in kawasaki disease J Am Coll Cardiol 2004;43:649–652 124 Sohn S, Kim HS, Lee SW Multidetector row computed tomography for follow-up of patients with coronary artery aneurysms due to kawasaki disease Pediatr Cardiol 2004;25:35–39 125 Schmidt WA Use of imaging studies in the diagnosis of vasculitis Curr Rheumatol Rep 2004;6:203–211 126 Kanamaru H, Sato Y, Takayama T, et al Assessment of coronary artery abnormalities by multislice spiral computed tomography in adolescents and young adults with kawasaki disease Am J Cardiol 2005;95:522–525 127 Dallair F, Fortier-Morissette Z, Blais S, et al Aspirin dose and prevention of coronary abnormalities in kawasaki disease Pediatrics 2017;e20170098; 10.1542/peds/2017-0098 [Epub ahead of print] 128 Baumer JH, Love SJ, Gupta A, et al Salicylate for the treatment of kawasaki disease in children Cochrane Database Syst Rev 2006;(4) [CD004175] 129 Catella-Lawson F, Reilly MP, Kapoor SC, et al Cyclooxygenase inhibitors and the antiplatelet effects of aspirin N Engl J Med 2001;345:1809–1817 130 Lee JH, Hung HY, Huang FY Kawasaki disease with reye syndrome: report of one case Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1992;33:67–71 131 Takahashi M, Mason W Kawasaki syndrome, Reye syndrome, and aspirin Pediatrics 1986;77:616–617 132 Takahashi M, Mason W, Thomas D, et al Reye syndrome following kawasaki syndrome confirmed by liver histopathology Kato H Kawasaki Disease: Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, 22-25 May 1995 Elsevier: New York, NY; 1995:436–444 133 Furusho K, Kamiya T, Nakano H, et al Highdose intravenous gammaglobulin for kawasaki disease Lancet 1984;2(8411):1055–1058 134 Mori M, Miyamae T, Imagawa T, et al Metaanalysis of the results of intravenous gamma globulin treatment of coronary artery lesions in kawasaki disease Mod Rheumatol 2004;14:361–366 135 Furusho K, Kamiya T, Nakano H, et al High dose intravenous gammaglobulin for kawasaki ... Dallair F, Fortier-Morissette Z, Blais S, et al Aspirin dose and prevention of coronary abnormalities in kawasaki disease Pediatrics 2017;e20170098; 10.1542/peds/2017-0098 [Epub ahead of print] 128 Baumer JH, Love SJ, Gupta A, et al... Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1992;33:67–71 131 Takahashi M, Mason W Kawasaki syndrome, Reye syndrome, and aspirin Pediatrics 1986;77:616–617 132 Takahashi M, Mason W, Thomas D, et al Reye syndrome following kawasaki syndrome